GAIN THERAPEUTICS INC (GANX:NASDAQ)
$1.87 0.07 (3.8889%)
Analysed GAIN THERAPEUTICS INC (GANX:NASDAQ) News Sources
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update
26-03-2026
yahoo.com
Gain Therapeutics Highlights GT-02287 Biomarker Signals, Eyes Phase 2 Start in Q3 at Roth Conference
24-03-2026
marketbeat.com
Gain Therapeutics to Present at the 38th Annual ROTH Conference
19-03-2026
yahoo.com
Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
18-03-2026
yahoo.com
Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update
12-03-2026
yahoo.com
Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference
19-02-2026
yahoo.com
Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week
07-01-2026
yahoo.com
Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287
06-01-2026
yahoo.com
Gain Therapeutics (GANX) Upgraded to Buy: Here's Why
22-12-2025
yahoo.com
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
18-12-2025
yahoo.com
What is the current price of GAIN THERAPEUTICS INC (GANX:NASDAQ)?
The current price of GAIN THERAPEUTICS INC (GANX:NASDAQ) is $1.87.
GAIN THERAPEUTICS INC (GANX:NASDAQ) absolute price change since previous trading day?
The absolute price change of GAIN THERAPEUTICS INC (GANX:NASDAQ) since the previous trading day is $0.07.
GAIN THERAPEUTICS INC (GANX:NASDAQ) percentage price change since previous trading day?
The percentage price change of GAIN THERAPEUTICS INC (GANX:NASDAQ) since the previous trading day is 3.8889%.
What is the most recent average sentiment score for GAIN THERAPEUTICS INC (GANX:NASDAQ)?
The most recent average sentiment score for GAIN THERAPEUTICS INC (GANX:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for GAIN THERAPEUTICS INC (GANX:NASDAQ)?
The most recent sentiment for GAIN THERAPEUTICS INC (GANX:NASDAQ) is .
SEC-8K** Filing Available For GAIN THERAPEUTICS INC (GANX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.